Ms Pascale Aeschlimann-Portner

MPhil

2023

• Aeschlimann-Portner, P. 2023. The impact of probiotic bacteria on intestinal barrier function. MPhil Thesis, Cardiff University.

2020

• Varricchio, C., Beirne, K., Aeschlimann, P., Heard, C., Rozanowska, M., Votruba, M. and Brancale, A. 2020. Discovery of Novel 2-Aniline-1,4-naphthoquinones as potential new drug treatment for Leber’s hereditary optic neuropathy (LHON). Journal of Medicinal Chemistry 63(22), pp. 13638 -13655. (10.1021/acs.jmedchem.0c00942)
• Hadjivassiliou, M., Reunala, T., Hervonen, K., Aeschlimann, P. and Aeschlimann, D. 2020. TG6 auto-antibodies in dermatitis herpetiformis. Nutrients 12(9), article number: 2884. (10.3390/nu12092884)

2019

• Hadjivassiliou, M. et al. 2019. Neurological deficits in patients with newly diagnosed coeliac disease are frequent and linked to TG6 autoimmunity. Clinical Gastroenterology and Hepatology 17(13), pp. 2678-2686.e2. (10.1016/j.cgh.2019.03.014)

2018

• Shanmugarajah, P. D. et al. 2018. Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics. Seizure - European Journal of Epilepsy 56, pp. 26-30. (10.1016/j.seizure.2018.01.019)
• De Leo, L. et al. 2018. Anti-transglutaminase 6 autoantibody development in children with celiac disease correlates with duration of gluten exposure. Journal of Pediatric Gastroenterology and Nutrition 66(1), pp. 64-68. (10.1097/MPG.0000000000001642)

2017

• Zis, P. et al. 2017. Transglutaminase 6 antibodies in gluten neuropathy. Digestive and Liver Disease 49(11), pp. 1196-1200. (10.1016/j.dld.2017.08.019)
• Tripathy, D. et al. 2017. Mutations in TGM6 induce the unfolded protein response in SCA35. Human Molecular Genetics 26(19), pp. 3749-3762. (10.1093/hmg/ddx259)

2016

• Shanmugarajah, P. D. et al. 2016. Alcohol-related cerebellar degeneration: not all down to toxicity?. Cerebellum & Ataxias 3, article number: 17. (10.1186/s40673-016-0055-1)
• Hadjivassiliou, M. et al. 2016. Neurological dysfunction in coeliac disease and non-coeliac gluten sensitivity. American Journal of Gastroenterology 111(4), pp. 561-567. (10.1038/ajg.2015.434)

2014

• Stenberg, R., Hadjivassiliou, M., Aeschlimann, P., Hoggard, N. and Aeschlimann, D. 2014. Anti-transglutaminase 6 antibodies in children and young adults with cerebral palsy. Autoimmune Diseases 2014, pp. 1-8., article number: 237107. (10.1155/2014/237107)

2013

• Hadjivassiliou, M. et al. 2013. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology 80(19), pp. 1740- 1745. (10.1212/WNL.0b013e3182919070)
• Thomas, H. et al. 2013. Transglutaminase 6: A protein associated with central nervous system development and motor function. Amino Acids 44(1), pp. 161-177. (10.1007/s00726-011-1091-z)

2010

• Sugai, E. et al. 2010. New Serology Assays Can Detect Gluten Sensitivity among Enteropathy Patients Seronegative for Anti-Tissue Transglutaminase. Clinical Chemistry 56(4), pp. 661-665. (10.1373/clinchem.2009.129668)

2009

• Hadjivassiliou, M., Aeschlimann, P. C. and Aeschlimann, D. 2009. TG6 ATAXIA. Journal of Neurology Neurosurgery and Psychiatry 80(11) (10.1136/jnnp.2009.191759q)

2008

• Hadjivassiliou, M., Aeschlimann, P. C., Strigun, A., Sanders, D. S., Woodroofe, N. and Aeschlimann, D. 2008. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Annals of Neurology 64(3), pp. 332-343. (10.1002/ana.21450)

2004

• Stephens, P. et al. 2004. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. Journal of cell science 117(15), pp. 3389-3403. (10.1242/jcs.01188)